Dr. Isla Garraway is an Associate Professor of Urology and Director of Research, Member of the Jonsson Comprehensive Cancer Center, and Member of the Broad Center for Regenerative Medicine and Stem Cell Research at UCLA.

Jun 15, 2007 · Isla Garraway was a researcher working toward her doctorate degree in a lab at UCLA’s Jonsson Comprehensive Cancer Center when her father was diagnosed with prostate cancer in 1994. He was just 61.

Dr. Isla Garraway's research focuses on mouse model development for the study of prostate and bladder cancer imaging and response to treatment.

Apr 1, 1994 · pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy. Prostate. 2025 Feb; 85 (3):252-264.

Today, Dr. Garraway’s focus at JCCC is developing ways to isolate specific stem cells from patients with prostate cancer. These cells constitute a certain fraction of all cells in the prostate, and have a unique ability to regenerate themselves.

Dr. Isla Garraway is an urologist in Los Angeles, California and is affiliated with multiple hospitals in the area, including Greater Los Angeles VA Medical Center and UCLA Medical Center. She...

Apr 30, 2023 · “Cancer is a heritable disease; prostate cancer is the most heritable of all cancers,” said Isla P. Garraway, MD, PhD, professor and director of research in urology at the David Geffen School of Medicine at the University of California, Los Angeles.

UCLA Health Medicare Advantage Plan includes Part D drug coverage. To enroll in UCLA Health Medicare Advantage Plan, you must have both Medicare Parts A and B and reside in the plan service area, Los Angeles County. In addition to your monthly plan premium, you must continue to pay your Medicare Part B premium.

Dr. Isla Garraway, MD is a board certified urologist in Los Angeles, California. She is affiliated with Greater Los Angeles HCS.

Nov 30, 2022 · Researcher and associate professor Isla Garraway joins Alicia Morgans in a discussion on ongoing prostate cancer research and current initiatives in the Veteran's Affairs (VA) Care Program.